Should you buy TrueBlue stock? (NYSE:TBI). Let's see how it does in our automated value investing analysis system.
(TrueBlue stock price per share)
||TBI Fair Price
(based on intrinsic value)
|TBI Safety Price (based on a variable margin of safety)||$18.05|
|PE Ratio versus Sector||208% higher than other Industrial Goods stocks|
|PE Ratio versus Industry||27% lower than other Staffing & Outsourcing Services stocks|
|Free Cash Flow Jitter||20%|
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 887,629 shares shorted. With 29,702,636 shares available for purchase and an average trading volume over the past 10 trading days of 157,140, it would take at least 5.649 days for all of the short holders to cover their shorts.
We believe that TrueBlue may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
TrueBlue looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.
Does TrueBlue have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles